Dice Therapeutics (DICE) Stock Price, News & Analysis
Company Description
Dice Therapeutics (NASDAQ: DICE) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $2.3B.
This page collects what Stock Titan holds for DICE, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Latest News
Dice Therapeutics has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 5 with negative movement. Key topics include acquisition, conferences, earnings. View all DICE news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
DICE Company Profile & Sector Positioning
Dice Therapeutics (DICE) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.
Investors comparing DICE often look at related companies in the same sector, including Ocular Therapeut (OCUL), Tarsus Pharmaceuticals, Inc. (TARS), Amicus Therapeut (FOLD), Liquidia Corporation (LQDA), and Travere Therapeutics Inc (TVTX). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate DICE's relative position within its industry.